The DOI matches its Crossref record; 633 of the 633 references it cites were found in a registry or an index.
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Open accessAbstract
Autoimmune disorders are characterized by aberrant T cell and B cell reactivity to the body’s own components, resulting in tissue destruction and organ dysfunction. Autoimmune diseases affect a wide range of people in many parts of the world and have become one of the major concerns in public health. In recent years, there have been substantial progress in our understanding of the epidemiology, risk factors, pathogenesis and mechanisms of autoimmune diseases. Current approved therapeutic interventions for autoimmune diseases are mainly non-specific immunomodulators and may cause broad immunosuppression that leads to serious adverse effects. To overcome the limitations of immunosuppressive drugs in treating autoimmune diseases, precise and target-specific strategies are urgently needed. To date, significant advances have been made in our understanding of the mechanisms of immune tolerance, offering a new avenue for developing antigen-specific immunotherapies for autoimmune diseases. These antigen-specific approaches have shown great potential in various preclinical animal models and recently been evaluated in clinical trials. This review describes the common epidemiology, clinical manifestation and mechanisms of autoimmune diseases, with a focus on typical autoimmune diseases including multiple sclerosis, type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus, and sjögren’s syndrome. We discuss the current therapeutics developed in this field, highlight the recent advances in the use of nanomaterials and mRNA vaccine techniques to induce antigen-specific immune tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–633 of 633
A population-based study on autoimmune disease
Wen, X., & Ли, Б. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00621-9 · Cited by 23
Raposo, C. J., Cserny, J. D., Serena, G., Chow, J., Cho, P., Liu, H., Kotler, D., Sharei, A., Bernstein, H., & John, S. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869669 · Cited by 22
siRNA-mediated c-Rel knockdown ameliorates collagen-induced arthritis in mice
Fan, T., Zhong, F., Liu, R., Chen, Y. H., Wang, T., & Ruan, Q. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.010 · Cited by 21
A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target
Yang, B., Zhao, M., Wu, H., & Lu, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.539797 · Cited by 21
Wan, X., Pei, W., Shahzad, K. A., Zhang, L., Song, S., Jin, X., Wang, L., Zhao, C., & Shen, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800108 · Cited by 19
Gorabi, A., Kiaie, N., Aslani, S., Jamialahmadi, T., Johnston, T., & Sahebkar, A. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102529 · Cited by 19
Soluble Antigen Arrays Efficiently Deliver Peptides and Arrest Spontaneous Autoimmune Diabetes
Firdessa-Fite, R., Johnson, S. N., Leon, M. A., Maharlooei, M. K., Baker, R. L., Sestak, J. O., Berkland, C. J., & Creusot, R. J. (2021) · Diabetes · doi:10.2337/db20-0845 · Cited by 19
Tissue‐Targeted Drug Delivery Strategies to Promote Antigen‐Specific Immune Tolerance
Rui, Y., Eppler, H. B., Yanes, A. A., & Jewell, C. M. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202238 · Cited by 19
Zheng, S., Shen, F., Jones, B. H., Fink, D., Geist, B. J., Nnane, I. P., Zhou, Z., Hall, J., Malaviya, R., Ort, T., et al. (2020) · mAbs · doi:10.1080/19420862.2020.1770018 · Cited by 18
Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides
Singh, R., Malosse, C., Davies, J. E., MALISSEN, B., Kochba, E., Levin, Y., Birchall, J. C., Coulman, S. A., Mous, J., McAteer, M. A., et al. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102321 · Cited by 18
Urbonaviciute, V., Romero‐Castillo, L., Xu, B., Luo, H., Schneider, N., Weisse, S., Do, N., Coelho, A., Lahore, G. F., Li, T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218668120 · Cited by 18
Moisini, I., Nguyen, P., Fugger, L. H., & Geiger, T. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3601 · Cited by 17
Lourbopoulos, A. I., Deraos, G., Matsoukas, M., Touloumi, O., Giannakopoulou, A., Kalbacher, H., Grigoriadis, N., Apostolopoulos, V., & Matsoukas, J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.005 · Cited by 17
Au, K. M., Tisch, R., & Wang, A. Z. (2021) · Advanced Materials · doi:10.1002/adma.202107392 · Cited by 17
Antiviral CD8+ T cells cause an experimental autoimmune encephalomyelitis-like disease in naive mice
Libbey, J. E., Cusick, M. F., Tsunoda, I., & Fujinami, R. S. (2012) · Journal of NeuroVirology · doi:10.1007/s13365-012-0077-2 · Cited by 16
Trager, N., Butler, J. T., Harmon, J. L., Mount, J., Podbielska, M., Haque, A., Banik, N. L., & Beeson, C. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0739-4 · Cited by 16
Wang, H., Shang, J., He, Z., Zheng, M., Jia, H., Zhang, Y., Yang, W., Gao, X., & Gao, F. (2022) · Biomaterials Science · doi:10.1039/d2bm00444e · Cited by 16
Sharifian, A., Varshosaz, J., Aliomrani, M., & Kazemi, M. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122936 · Cited by 16
Qian, Z., Latham, K. A., Whittington, K. B., Miller, D. C., Brand, D. D., & Rosloniec, E. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300024 · Cited by 15
ECTRIMS 2019 – Late Breaking News Abstracts
Kerbrat, A., Gros, C., Badji, A., Bannier, É., Combès, B., Galassi, F., Labauge, P. M., Ayrignac, X., Dalliere, C. C., Pinna, F., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519869496 · Cited by 15
Li, J., Qiu, D., Liu, Y., Xiong, J., Wang, Y., Yang, X., Fu, X., Zheng, L., Luo, G., Xing, M. M. Q., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b06575 · Cited by 14
Self-citationSoluble Antigen Arrays Displaying Mimotopes Direct the Response of Diabetogenic T Cells
Leon, M. A., Firdessa-Fite, R., Ruffalo, J. K., Pickens, C. J., Sestak, J. O., Creusot, R. J., & Berkland, C. J. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00090 · Cited by 13
Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetesPreprint
Spanier, J. A., Fung, V. C. W., Wardell, C. M., Alkhatib, M. H., Chen, Y., Swanson, L. A., Dwyer, A. J., Weno, M. E., Silva, N., Mitchell, J. S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.23.529737 · Cited by 13
Yang, Y., & Santamaría, P. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.12.012 · Cited by 12
Keeler, G. D., Gaddie, C. D., Sagadevan, A. S., Senior, K. G., Côté, I., Rechdan, M. N., Min, D., Mahan, D., Poma, B., & Hoffman, B. E. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.12.011 · Cited by 12
Kalinčík, T., Sharmin, S., Roos, I., Massey, J. C., Sutton, I., Withers, B., Freedman, M. S., Atkins, H. L., Krasulová, E., Havrdová, E., et al. (2024) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332790 · Cited by 12
Gudi, R. R., Karumuthil‐Melethil, S., Perez, N., Li, G., & Vasu, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-48464-y · Cited by 11
Christofi, M., Sommer, S. L., Mölzer, C., Klaska, I. P., Kuffová, L., & Forrester, J. V. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03672-y · Cited by 11
Mechanisms of antigen-induced reversal of CNS inflammation in experimental demyelinating disease
Li, J., Lu, L., Binder, K., Xiong, J., Ye, L., Cheng, Y. H., Majri-Morrison, S. S., Lü, W., Lee, J. W., Zhang, Z., et al. (2023) · Science Advances · doi:10.1126/sciadv.abo2810 · Cited by 10
Self-citationModulation of CD4 T cell function by soluble MHC II-peptide chimeras
Casares, S. A., Bona, C. A., & Brumeanu, T. (2001) · International Reviews of Immunology · doi:10.3109/08830180109045578 · Cited by 9
Adoptive transfer of GRP78-treated dendritic cells alleviates insulitis in NOD mice
Zhou, X., Yang, M., Lv, Y., Li, H., Wu, S., Min, J., Shen, G., He, Y., & Lei, P. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma0921-219rrrr · Cited by 9
Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes
Postigo, J., Firdessa-Fite, R., & Creusot, R. J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110987119 · Cited by 9
Elahi, E., Ali, M. E., Zimmermann, J., Getts, D. R., Müller, M., & Lamprecht, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112410 · Cited by 6
Metadata
- Authors
- Song, Y., Li, J., & Wu, Y.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-10-04
- Volume
- 9
- Issue
- 1
- Pages
- 263-263
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4403086871
- Cited by
- 259
- References
- 633
- FWCI
- 35.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.